890840-90-1

Basic information

• Product Name: 7,8-difluorochroman-4-one
• Synonyms: 7,8-difluorochroman-4-one;7,8-Difluoro-2,3-dihydro-4H-1-benzopyran-4-one
• CAS NO: 890840-90-1
• Molecular Formula: C9H6F2O2
• Molecular Weight: 184.1395464
• Mol File: 890840-90-1.mol

Chemical Properties

• Boiling Point: 293℃
• Flash Point: 127℃
• Appearance: /
• Density: 1.392
• Vapor Pressure: 0.002mmHg at 25°C
• Refractive Index: 1.519
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 7,8-difluorochroman-4-one(CAS DataBase Reference)
• NIST Chemistry Reference: 7,8-difluorochroman-4-one(890840-90-1)
• EPA Substance Registry System: 7,8-difluorochroman-4-one(890840-90-1)

Safety Data

• Hazardous Substances Data: 890840-90-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
7,8-difluorochroman-4-one is used as a pharmaceutical precursor for the development of new compounds with potential therapeutic applications. Its antioxidant and anti-inflammatory properties make it a promising candidate for the treatment of various diseases and conditions.
Used in Chemical Industry:
7,8-difluorochroman-4-one is utilized as a key intermediate in the synthesis of a wide range of chemical compounds. Its unique structure and functional groups enable the creation of novel molecules with diverse applications in various chemical processes and industries.

InChI:InChI=1/C9H6F2O2/c10-6-2-1-5-7(12)3-4-13-9(5)8(6)11/h1-2H,3-4H2

Upstream product

• 1310116-22-3 3-(2,3-difluorophenoxy)propionic acid 
• 6418-38-8 2,3-difluorophenol 
• 890840-88-7 1,2-difluoro-3-(prop-2-yn-1-yloxy)benzene 

Relevant articles and documents

NOVEL ARYL UREA DERIVATIVE

There is a need for FAAH inhibitors capable of oral administration and having excellent efficacy, particularly agents for the prevention and treatment of pain. Disclosed are novel arylurea compounds represented by formula (I), salts or solvates thereof, and pharmaceutical compositions comprising the same as an active ingredient. The pharmaceutical composition is used primarily for FAAH inhibitors, or agents for prevention and treatment of pain.

Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof

Compounds that are antagonists of the VR1 receptor, having formula (I) [image] or a pharmaceutically acceptable salt, prodrug, or salt of a prodrug thereof, wherein A1, A2, A3, A4, R7, R8, R9, X, Y, Z, L, n, and m, are as defined herein, and are useful in disorders prevented or ameliorated by inhibiting the VR1 receptor.